SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia with Venous Thrombosis, Pulmonary Embolism, and Adrenal Haemorrhage: A Case Report with Literature Review

URN to cite this document:: urn:nbn:de:bvb:355-epub-521566
DOI to cite this document:: 10.5283/epub.52156

Tews, Hauke Christian ; Driendl, Sarah M. ; Kandulski, Melanie ; Buechler, Christa

; Heiss, Peter ; Stöckert, Petra Diana ; Heissner, Klaus ; Paulus, Michael G.

; Kunst, Claudia ; Müller, Martina ; Schmid, Stephan

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(38kB)

Date of publication of this fulltext: 14 Apr 2022 13:48

Alternative links to fulltext:DOI Publisher Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Vaccine-induced immune thrombotic thrombocytopenia (VITT) with venous thrombosis is a rare complication of SARS-CoV-2 vaccination with ChAdOx1 (AstraZeneca) and AD26.COV2.S (Johnson & Johnson, New Brunswick, NJ, USA) associated with high mortality. At present, there are no known differences in the pathophysiology or risk factors of VITT with the AstraZeneca vaccine (ChAdOx1) compared with the ...